Janelidze et al. (2015), measured CSF neurogranin and YKL-40 levels in a cohort of 338 individuals including cognitively healthy controls and patients with sporadic MCI, MCI which later developed AD, PD, DLB, VaD, and FTD patients. This evidence concerns the gene NRGN and Lewy body dementia.